Vertex Announces Positive Results From Phase 2 Study of VX-147 i

VRTX: Vertex Pharmaceuticals Incorporated
2021-12-01 07:30:00
Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis